Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea by Park, Sohee et al.
RESEARCH ARTICLE Open Access
Attributable fraction of alcohol consumption on
cancer using population-based nationwide cancer
incidence and mortality data in the Republic of
Korea
Sohee Park1,2, Hai-Rim Shin1,3*, Boram Lee1, Aesun Shin1,4, Kyu-Won Jung1, Duk-Hee Lee5, Sun Ha Jee6,
Sung-Il Cho7, Sue Kyung Park4,8, Mathieu Boniol9, Paolo Boffetta10 and Elisabete Weiderpass11,12,13,14
Abstract
Background: In the Republic of Korea, cancer is the most common cause of death, and cancer incidence and
mortality rates are the highest in East Asia. As alcoholic beverages are carcinogenic to humans, we estimated the
burden of cancer related to alcohol consumption in the Korean population.
Methods: The cancer sites studied were those for which there is convincing evidence of a positive association with
alcohol consumption: oral cavity, pharynx, esophagus, colon, rectum, liver, larynx and female breast. Sex- and
cancer-specific population attributable fractions (PAF) were calculated based on: 1) the prevalence of alcohol
drinkers among adults ≥20 years of age in 1989; 2) the average daily alcohol consumption (g/day) among drinkers
in 1998; 3) relative risk (RR) estimates for the association between alcohol consumption and site-specific cancer
incidence obtained either from a large Korean cohort study or, when more than one Korean study was available for
a specific cancer site, meta-analyses were performed and the resulting meta-RRs were used; 4) national cancer
incidence and mortality data from 2009.
Results: Among men, 3% (2,866 cases) of incident cancer cases and 2.8% (1,234 deaths) of cancer deaths were
attributable to alcohol consumption. Among women, 0.5% (464 cancer cases) of incident cancers and 0.1% (32
deaths) of cancer deaths were attributable to alcohol consumption. In particular, the PAF for alcohol consumption
in relation to oral cavity cancer incidence among Korean men was 29.3%, and the PAFs for pharyngeal and
laryngeal cancer incidence were 43.3% and 25.8%, respectively. Among Korean women, the PAF for colorectal
cancer incidence was the highest (4.2%) and that for breast cancer incidence was only 0.2%. Avoiding alcohol
consumption, or reducing it from the median of the highest 4th quartile of consumption (56.0 g/day for men,
28.0 g/day for women) to the median of the lowest quartile (2.80 g/day for men, 0.80 g/day for women), would
reduce the burden of alcohol-related cancers in Korea.
Conclusions: A reduction in alcohol consumption would decrease the cancer burden and a significant impact is
anticipated specifically for the cancers oral cavity, pharynx, and larynx among men in the Republic of Korea.
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Background
Cancer is the main cause of death in the Republic of
Korea, and cancer incidence rates in Korea are the highest
in all of East Asia [1,2]. Cancer incidence rates, in particu-
lar for cancers of the colon and rectum, breast, thyroid
and prostate, have increased significantly during the last
10 years, with an average annual increase of 3.1% for all
cancer sites combined [3]. The human, social and eco-
nomic aspects of the cancer burden are major concerns
for the Korean society and its government [4]. Under-
standing how cancer morbidity and mortality can be
prevented, and thereby controlled, would contribute to
the country’s public health agenda [5].
According to the Global Status Report on Alcohol and
Health, the worldwide consumption of pure alcohol was
6.13 liters/year per person aged 15 years or older in 2005
[6]. There are large geographic differences in consumption
patterns, as well as, in most populations, between men
and women [6]. Although about half of the world’s popu-
lation abstains from alcohol consumption, nearly 2 billion
adults consume an average of 13 g/day of ethanol (about
one drink) [7].
Several studies, mainly among Whites in Europe and
North America, have shown that alcohol consumption
has a dual effect on mortality, resulting in a U-shaped
overall mortality curve, with lifetime non-drinkers and
heavy drinkers having the highest overall mortality risk
compared to moderate drinkers. This effect reflects the
beneficial impact that light to moderate drinking can
have on morbidity and mortality due to ischemic heart
disease and ischemic stroke, though this beneficial
impact disappears with heavy drinking. Nevertheless,
alcohol consumption also has deleterious health ef-
fects, such as hypertension, cardiac dysrhythmias and
hemorrhagic stroke [8]. Therefore, the overall effect of
alcohol consumption on the disease burden in a popula-
tion depends on the distribution of consumption patterns
and the background incidence of various alcohol-related
diseases. According to the recent evaluation by Inter-
national Agency for Research on Cancer, there is suffi-
cient evidence that alcohol consumption causes cancers
of the oral cavity, pharynx, esophagus, colon, rectum,
liver, larynx, and female breast, while evidence for pan-
creatic cancer is limited. It is known that there is about
10% increased risk of getting breast cancer per alcohol
consumption of 10 g/day among women [7,9].
In 2003–2005 the average adult per capita consump-
tion of pure alcohol in Korea was estimated to be 14.8
liters per year, 81% of which was in the form of spirits
[6]. The proportion of lifetime non-drinkers in Korea
has been decreasing in the past decades among both
men (25.4% in 1992; 10.1% in 1998; 12.4% in 2001; 5.3%
in 2005) and women (77.4% in 1992; 41.3% in 1998;
38.2% in 2001; 19.2% in 2005) [10]. It was estimated that
in 1998 89.9% of Korean men and 58% of Korean
women were alcohol drinkers, with a mean consump-
tion of 28.53 g/day among men and 6.38 g/day among
women [10]. Further surveys in Korea indicated a de-
creasing trend in the mean consumption of pure alcohol
among men (28.53 g/day in 1998; 26.68 g/day in 2001;
25.33 g/day in 2005), and a slightly increasing trend
among women (6.38 g/day in 1998; 5.70 g/day in 2001;
7.92 g/day in 2005) [10].
We conducted a systematic analysis of attributable
causes of cancer in Korea, and herein we report esti-
mates of the cancer burden caused by alcohol consump-
tion in the country.
Methods
Prevalence of alcohol consumption in Korea
In the present analysis, the prevalence of alcohol con-
sumption in Korea was estimated based on 1) the pro-
portion of alcohol drinkers (the persons who reported
non-zero frequency of drinking) among adults aged
20 years or older, and 2) the average alcohol consump-
tion (g/day) among alcohol drinkers. Assuming a latency
period of approximately 20 years between alcohol drinking
exposure and the cancer occurrence, data from the 1989
Korean National Health Examination Surveys (KNHES)
was used to estimate the proportion of alcohol drinkers
(Additional file 1: Table S1). Average alcohol consumption
(g/day) among alcohol drinkers was calculated based on
the type of alcoholic beverage, frequency and amount of
usual consumption among individuals who participated in
the 1998 Korean National Health and Nutrition Examin-
ation Surveys (KNHANES), as this information was not
available in the 1989 surveys (Additional file 1: Table S2).
Because KNHES and KNHANES data do not contain per-
sonal information and are publically available through on-
line request (http://knhanes.cdc.go.kr/knhanes/), we did
not have to address ethical concerns.
Identification of Korean studies on alcohol consumption
and cancer
Studies reporting relative risks (RRs) of alcohol con-
sumption and cancer in Korean populations, and pub-
lished through August 1, 2012 were identified using the
databases PubMed (http://www.ncbi.nlm.nih.gov/pubmed/)
and KoreaMed (http://www.koreamed.org/SearchBasic.
php). The search keywords were “Korea”, “alcohol”, “risk”,
and “cancer.” Language was limited to English or Korean.
At least two independent investigators performed litera-
ture search and reviewed articles. We also reviewed refer-
ences cited from retrieved articles to identify additional
studies for inclusion. When there were multiple reports of
a single study, the publication with the longest follow-up
period or the largest number of cases was selected. When
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necessary, we also obtained additional data through per-
sonal communication with the authors of the studies.
Twenty six studies were initially identified [11-35], 14
of which were subsequently excluded because only the
RR for drinkers vs. non-drinkers (defined differently in
each study) was available, and the dose–response rela-
tionship could not be ascertained. One study was ex-
cluded because the number of cases for each exposure
category was not presented [13] and another study was
excluded due to an overlapping study populations [17].
Additional RR results from updated data with a longer
follow-up period (until December 2006), and analyses
adjusting for further confounding variables such as age
and smoking, were obtained through personal commu-
nication [17,18]. Therefore, ten studies, including a
large-scale population-based prospective study, were
used in the final calculation of RRs for alcohol con-
sumption as they provided the necessary information to
assess the dose–response relationship between alcohol
consumption and cancer [11,14,15,19,22,25,28,29,31,33].
Relative risk estimates of cancer according to alcohol
consumption in Korea
RRs of alcohol-related cancers per 1 g/day increase in
alcohol consumption were estimated by a dose–response
analysis of the ten selected studies described above. With
different categories of alcohol intake in different studies,
we fit a log-linear regression by taking the log of relative
risk (or odds ratio) as Y values and taking the midpoint of
alcohol consumption for each category as X values to esti-
mate the slope β (log(RR)) for dose–response relationship.
From each study, the log(RR) per one gram increase of
alcohol consumption on a continuous scale was esti-
mated, then they were used for meta-analysis to estimate
the summary log(RR) per one gram increase of alcohol
consumption. Because the relationship between the alco-
hol consumption and relative risk is better captured in a
log-linear relationship instead of a linear relationship, the
dose–response relationship between alcohol consumption
and RR was estimated through log(RR).
A meta-analysis was performed to estimate the pooled
RRs for average alcohol consumption based on relevant
studies. Separate RRs were estimated for cancer incidence
and mortality where possible and when the RR for cancer
mortality was not available, the RR for cancer incidence
for each cancer site was used for cancer mortality. In cases
of heterogeneity across studies, as examined by I2 (I2 ≥ 80)
and Q statistics (p < 0.05), the risk estimates from a
random-effects model were used [36]. Publication bias
was checked by funnel plot and Begg’s test. The “Metan”
command in Stata (version 11.0; StataCorp, College
Station, Texas, USA) and Comprehensive Meta-Analysis
version 2 (Biostat, Englewood, New Jersey, USA) were
used to perform meta-analyses.
Alcohol-associated cancer sites and data sources for
cancer cases and deaths
Cancer sites for which convincing evidence of a positive
association with alcohol consumption exists [7,37], and
for which RR estimates in Korea were available, were con-
sidered in this report: oral cavity, pharynx, esophagus,
colon, rectum, liver, larynx and female breast. The number
of incident cancer cases in 2009 at sites included in this
report was obtained from the Korean Central Cancer
Registry, a population-based nationwide cancer registry
which is described in more detail elsewhere [3]. The num-
ber of cancer deaths in 2009 was obtained using death cer-
tificate data from the Korean National Statistics Office [1].
Because we used the aggregated data that do not contain
personal information and that are publically available
through website (http://www.cancer.go.kr for cancer inci-
dence statistics; and http://www.kosis.kr for cancer mortal-
ity statistics), we did not have to address ethical concerns.
Estimation of population attributable fraction
The sex- and cancer site-specific population attributable
fraction (PAF) for alcohol consumption for the year 2009
in Korea was calculated by the following Levin’s formula
[38], but applied for continuous exposure [39]:
PAF ¼ P RR−1ð Þ
P RR−1ð Þ þ 1 ¼
P eβdose−1
 
P eβdose−1ð Þ þ 1 ;
where β = log(RR) , and the RR corresponds to that as-
sociated with a specific cancer site for a 1-unit increase
in alcohol consumption, P is the proportion of alcohol
drinkers and dose is the average alcohol consumption
(in g/day as a continuous variable) among drinkers in
the total population.
Where possible, we estimated the PAFs for cancer inci-
dence and mortality separately. However, we used the same
RR for cancer incidence and mortality, that is, we assumed
that alcohol drinking has no effect on cancer survival. The
Description of research flow for the PAF calculation and
relevant data sources are presented in Figure 1. Using the
conventional Delta method [40,41], we computed 95%
confidence intervals (CI) for the PAF estimates, which
turned out to be very narrow for all estimates. Hence,
we did not include these in our results, and instead pre-
sented the sensitivity analysis as described below.
Sensitivity analysis and analysis of changes in the
population attributable fraction by different alcohol
consumption prevalence scenarios
Sensitivity analyses were performed on the PAFs for
alcohol consumption using the lower and upper bounds
of the 95% CIs of RR estimates. We also investigated the
changes in PAF under two hypotheses: 1) that all individ-
uals had high alcohol consumption (4th quartile) and 2)
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that all individuals had low alcohol consumption (1st
quartile) within each sex.
Results
Relative risks estimates of cancer according to alcohol
consumption in Korea
The estimated RRs of cancer for the studies included in
the present report are shown in Table 1, and a complete
summary of these studies is shown in Additional file 1:
Table S3. For all cancer sites included in this report, al-
cohol consumption was considered among individuals
aged 20 years or older. However, for colon cancer there
were additional studies carried out in 1993–1998 con-
cerning alcohol consumption at 65 years of age or older,
and for liver cancer an additional case–control study
carried out in 1990–1993 reported on alcohol consump-
tion at age 39 years or older. The pooled RRs corre-
sponding to average alcohol consumption for cancer of
the oral cavity, pharynx, and larynx were high, ranging
from 1.45 to 1.98 in men. Among women, the pooled
RR for average alcohol consumption was highest, though
not significant, in colorectal cancer (pooled RR = 1.19),
followed by pharyngeal cancer (RR = 1.17) and oral cav-
ity cancer (pooled RR = 1.10) (Table 1, Additional file 1:
Table S3).
Population attributable fraction
The PAF for alcohol consumption, the number of in-
cident cancer cases and cancer deaths attributable to
alcohol consumption overall and by sex are shown in
Table 2 by cancer site. The PAF was higher in men
(3.0%; 2,866 incident cancer cases, 2.8%, 1,234 cancer
deaths) (Figure 2A) than in women (0.5%; 464 inci-
dent cancer cases and of 0.1%, 32 cancer deaths)
(Figure 3A).
Among men, the PAF of cancer incidence for alcohol
consumption was particularly high in relation to pharyngeal
(43.3%), oral cavity (29.3%), laryngeal (25.8%), esophageal
(8.6%) and colorectal (8.6%) cancers, and relatively lower
for liver cancer (4.4%) (Table 2). However, given the differ-
ences in the underlying incidence between cancer sites,
the total number of avoidable incident cancer cases in
men was largest for colon (676), followed by rectal (605),
liver (508), oral cavity (330), pharyngeal (304) and laryn-
geal (276) cancer (Figure 2B). The PAF of cancer mortality
for alcohol consumption was also the highest in oral cavity
(24%) and pharyngeal (24%) cancer, followed by esopha-
geal (20.4%), laryngeal (18.5%), liver (6.5%) and colorectal
(4.4%) cancer. The total number of avoidable deaths in
men was 545 for liver, 264 for esophageal, 71 for laryngeal,
96 for colon, 75 for rectal, 95 for oral cavity and 88 for
pharyngeal cancers (Table 2).
Among women, the cancer site with the highest
number of cases that could have been prevented by
avoidance of alcohol consumption was colorectal can-
cer (414 cases), followed by breast (20 cases), oral
cavity (12 cases), liver (12 cases), oral cavity (12
cases) and pharyngeal (4 cases) cancer (Figure 3B).
Figure 4 shows the results of the sensitivity analysis
of the PAFs for alcohol consumption using the lower
Figure 1 Description of research flow for the PAF calculation and relevant data sources.
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and upper bounds of the 95% CIs of RR estimates.
The upper bound of the CI for female pharyngeal
cancer was 5.0%, that for breast cancer was close to
5.5% and that for female colorectal cancer was close
to 12.0% (Figure 4). There has been wide variation
due to uncertainty of the RR estimates.
Changes in population attributable fraction by different
alcohol consumption prevalence scenarios
Table 3 shows the PAF calculations using different hypo-
thetical scenarios of alcohol consumption, namely the
overall median (men: 28.53 g/day, women: 6.38 g/day), as
well as the median of the highest (4th) quartile of
Table 1 Estimated relative risks (RR) and 95% confidence intervals (CI) of cancer by sex in Korea
Cancer site (ICD-10
code)
Men Women Source of
Pooled RR
or OR
Log (Risk per g/day) RR for averaged
consumption
Log (Risk per g/day) RR for averaged
consumption
Incidence
Oral cavity (C00-09) 0.015 1.53 (0.77-2.96) 0.015a 1.10 (0.94-1.27) [17]
[12]
Pharynx (C10-C14)b 0.024 1.98 (1.62-2.42) 0.024a 1.17 (1.11-1.22) [12]
Esophagus (C15) 0.004 1.12 (1.00-1.26) 0.004a 1.03 (1.00-1.05) [17]
[22]
Colon (C18) 0.004 1.12 (0.80-1.53) 0.027 1.19 (0.88-1.60) [17]
[25]
[19]
Rectum (C20)b 0.004 1.12 (0.80-1.53) 0.027 1.19 (0.88-1.60) [17]
[25]
[19]
Liver (C22) 0.002 1.06 (1.03-1.09) 0.002a 1.01 (1.01-1.02) [17]
[28]
Larynx (C32) 0.013 1.45 (0.82-2.56) 0.013a 1.09 (0.96-1.23) [17]
[12]
Breast in women (C50) - - 0.001 1.01 (0.99-1.02) [14]
[33]
Mortality
Oral cavity (C00-09) 0.012 1.41 (1.22-1.67) 0.012a 1.08 (1.05-1.12) [18]
Pharynx (C10-C14) 0.012 1.41 (1.22-1.67) 0.012a 1.08 (1.05-1.12) [12]
Esophagus (C15) 0.010 1.33 (1.12-1.62) 0.010a 1.07 (1.03-1.11) [18]
[22]
[29]
[34]
Colon (C18) 0.002 1.06 (0.94-1.19) 0.002a 1.01 (0.99-1.04) [18]
[29]
Rectum (C20)b 0.002 1.06 (0.94-1.19) 0.002a 1.01 (0.99-1.04) [18]
[29]
Liver (C22) 0.003 1.09 (1.06-1.15) 0.003a 1.02 (1.01-1.03) [18]
[29]
Larynx (C32) 0.009 1.29 (1.09-1.49) 0.009a 1.06 (1.02-1.09) [18]
Breast in women (C50) - - 0.001c 1.01 (0.99-1.02) [14]
[33]
Notes: Reference category = non-drinkers (never drinkers + former drinkers).
aUsing log(RR) in men. bUsing log(RR) of colon. cUsing log(RR) for cancer incidence in women. dAverage alcohol consumption: 28.53 g/day in men, 6.38 g/day in
women (1998 National Health and Nutrition Examination Survey) [42,43].
Abbreviations: ICD International Classification of Diseases.
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consumption (men: 56.0 g/day, women: 28.0 g/day) and
median of the lowest (1st) quartile (men: 2.80 g/day,
women: 0.80 g/day) [10]. This analysis indicated that if all
alcohol drinkers were to consume the same median
amount of alcohol as people in the lowest quartile of alco-
hol consumption, as opposed to the median amount con-
sumed by those in the highest quartile, a substantial
proportion of incident cancer cases, and consequently can-
cer deaths, would be avoided. This potential risk reduction
would apply to both sexes. For example, the PAF for alco-
hol consumption in men would decrease from 50.5% to
3.2% for oral cavity cancer, from 68.7% to 5.1% for
pharyngeal cancer, and from 45.4% to 2.8% for laryngeal
cancer. Among women, the PAF for alcohol consumption
would be most substantially reduced for colon and rectal
cancer (from 21% to 0.5%), but the reduction would also be
noticeable for pharyngeal cancer (from 18.4% to 0.5% for
each). Furthermore, if Korean male drinkers reduced their
alcohol consumption, such as beer or soju (Korean rice
wine), by one glass (approximately 12 g) per day, the total
cancer burden attributable to alcohol consumption would
be reduced approximately by 1.7%, which implies that we
could save about 1,617 cancer patients.
Sensitivity analysis showed that the PAF estimates
were more sensitive due to higher uncertainty in RR es-
timates in oral cavity, colorectal and laryngeal cancers.
However, for pharyngeal and liver cancers, the PAF esti-
mates were less sensitive (Figure 4).
Discussion
To our knowledge, this is the first study to estimate the
PAF for alcohol consumption in relation to cancer risk in
Korea, using both alcohol consumption estimates and
cancer-related RRs from Korean studies. Our estimates
therefore take into account aspects such as the specific car-
cinogenic effect of alcohol consumption in Korea, and the
genetic susceptibility of this population.
As expected, we found that the PAF for alcohol con-
sumption in Korean men was higher than that in Korean
women. Among men, 3% of incident cancer cases and 2.8%
of cancer deaths were attributable to alcohol consumption.
Among the cancer sites included in this report, the PAF for
alcohol consumption in men was the largest in relation to
pharyngeal cancer (43.3%) and oral cavity (29.3%). However,
colorectal and liver cancers had the highest number of
avoidable incident cancer cases and deaths due to their high
incidence in Korea. Among women only 0.5% of incident
cancer cases and 0.1% of cancer deaths were attributable to
alcohol consumption; the main cancer types that could
have been prevented were colorectal cancer (4.2%),
followed by pharyngeal cancer (3.7%).
If changes in patterns of alcohol consumption were to
occur in Korea, with people in the highest quartile of alco-
hol consumption diminishing their consumption to the
level of those in the lowest quartile, a substantial decrease
in the PAF would occur, most notably among men, de-
creasing by 64% the number of pharyngeal cancer cases,
decreasing by 47% of oral cavity cancer cases, and decreas-
ing by 43% the number of laryngeal cancer cases. Among
women, the reductions in risk would be more modest, but
still substantial, in particular for colorectal and pharyngeal
cancers. For colorectal cancer, reductions in incidence
could be up to 20% if we consider the upper bound of the
95% CIs of the PAF estimates.
In our study, the PAF estimates for alcohol consumption
in relation to cancer incidence and mortality in Korea
Table 2 PAF and number of cancer cases and cancer deathsa attributable to alcohol consumption, Korea, 2009
Cancer site
(ICD-10 code)
Men Women
PAF No. of
cases
Alcohol -related
cases
PAF No. of
deaths
Alcohol -related
deaths
PAF No. of
cases
Alcohol -related
cases
PAF No. of
deaths
Alcohol -related
deaths
Oral cavity
(C00-C09)
29.3 1,128 330 24.0 397 95 2.3 512 12 1.8 153 3
Pharynx
(C10-C14)b
43.3 703 304 24.0 368 88 3.7 114 4 1.8 55 1
Esophagus
(C15)
8.6 1,947 167 20.4 1,297 264 0.6 175 1 1.5 109 2
Colon (C18) 8.6 7,886 676 4.4 2,206 96 4.2 4,643 236 0.3 1,978 6
Rectum (C20)c 8.6 7,063 605 4.4 1,722 75 4.2 3,458 178 0.3 1,142 3
Liver (C22) 4.4 11,663 508 6.5 8,422 545 0.3 3,539 12 0.5 2,814 13
Larynx (C32) 25.8 1,071 276 18.5 382 71 2.0 56 1 1.4 1,878 1
Female breast
(C50)
- - - - - 0.2 11,536 20 0.2 395 3
Total 96,826 2,866 43,658 1,234 91,068 464 25,773 32
% of all cancers 3.0 2.8 0.5 0.1
Notes: aCases and deaths are from adults (aged 20 years and older). bUsing relative risk of oral cavity. cUsing relative risk of colon.
Abbreviations: ICD International Classification of Diseases, PAF population attributable fraction.
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were generally lower than corresponding estimates else-
where. Boffetta et al. [44] estimated a PAF for alcohol
consumption in relation to cancer incidence worldwide
of 3.6% (5.2% in men, 1.7% in women) and 3.5% for can-
cer mortality (5.1% in men, 1.3% in women). Other
worldwide estimates for cancer mortality indicated a
PAF for alcohol consumption of 5% for all cancers com-
bined [6,45]. A few studies in specific populations using
a methodology similar to ours have been published
recently. A study in China considered cancers of the
oral cavity, pharynx, esophagus, colon-rectum, liver and
larynx, which have a firmly established association with
alcohol consumption. Their PAF estimate for alcohol
consumption in relation to overall cancer incidence was
3.63% (5.92% for men and 0.31% for women), and 4.40%
(6.69% in men, 0.42% in women) for overall cancer mor-
tality [46]. In France the PAF for cancer mortality was
estimated to be 6.9% (9.4% in men and 3.0% in women)
Figure 3 Number of cancer incident cases attributable to alcohol consumption in Korean women, 2009*. * A) Proportion of cancer
incident cases attributable to alcohol consumption; B) Number of cancer incident cases attributable to alcohol consumption by cancer sites
Figure 2 Number of cancer incident cases attributable to alcohol consumption in Korean men, 2009*. * A) Proportion of cancer incident
cases attributable to alcohol consumption; B) Number of cancer incident cases attributable to alcohol consumption by cancer sites.
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[47]. A study conducted in the Russian Federation using
a different methodology [48] indicated a much higher
PAF for alcohol consumption in relation to several can-
cer sites due to the fact that mean alcohol consumption
in the country is 26.71 liters of pure alcohol per person
per year.
As in the studies performed in China [46] and France
[47], we only considered cancers for which a firmly
established association with alcohol consumption exists
[7]. In particular, pancreatic cancer was not consid-
ered in our PAF estimates, as the association with al-
cohol consumption is still not considered to be firmly
established, despite several studies suggesting an increased
risk of this cancer among alcohol drinkers [7,49]. There-
fore our estimate may be somewhat lower than the real
PAF for alcohol consumption in relation to cancer inci-
dence in Korea.
Differences between our PAF estimates for Korea and
those found elsewhere may be caused both by differ-
ences in the methodologies used (for example the RR
used for incidence and mortality calculations for each
cancer site varied substantially between the studies
included in this report), and by patterns of alcohol
consumption, namely the proportion of drinkers and
Figure 4 Sensitivity analysis of the PAF for alcohol consumption*. *Lower and upper bounds of 95% CIs for RR estimates used. PAF: population
attributable fraction, CI: confidence interval, RR: relative risk.
Table 3 PAF for alcohol consumption by different consumption scenarios
Cancer
site
Men Women
PAF(%)a PAF (Q4)b PAF (Q1)c PAF (Q4-Q1) PAF(%)a PAF (Q4)b PAF (Q1)c PAF (Q4-Q1)
Oral cavity 29.3 50.5 3.2 47.3 2.3 10.9 0.3 10.6
Pharynx 43.3 68.7 5.1 63.6 3.7 18.4 0.5 17.9
Esophagus 8.6 16.3 0.9 15.4 0.6 2.7 0.1 2.6
Colon 8.6 16.3 0.9 15.4 4.2 21.0 0.5 20.5
Rectumd 8.6 16.3 0.9 15.4 4.2 21.0 0.5 20.5
Liver 4.4 8.4 0.4 8.0 0.3 1.3 0.0 1.3
Larynx 25.8 45.4 2.8 42.6 2.0 9.4 0.3 9.1
Breast - 0.2 0.7 0.0 0.6
aMen: 28.53 g/day, women: 6.38 g/day (’98 Korea National Health and Nutrition Examination Survey) [42,43].
bMedian alcohol consumption in the highest (4th) quartile was 56.0 g/day for men and 28.0 g/day for women.
cMedian alcohol consumption in the lowest (1th) quartile was 2.80 g/day for men and 0.80 g/day for women.
dUsing RR of colon.
Abbreviations: PAF Population attributable fraction, Q Quartile.
Park et al. BMC Cancer 2014, 14:420 Page 8 of 12
http://www.biomedcentral.com/1471-2407/14/420
non-drinkers, and, among drinkers, the mean amounts
consumed [6,10,44-46,50]. Our PAF estimates were based
on the proportion of alcohol drinkers over 20 years of
age in Korea in 1989 and the estimated daily alcohol
consumption in 1998 (mean 28.53 g/day for men, and
6.38 g/day for women) [10], as well as on the RR of cancer
incidence and mortality according to alcohol consumption
in Korea, which is different than elsewhere (e.g., China).
The World Health Organization Global Status Report
on Alcohol and Health [6] provides estimates of alcohol
consumption in different countries, as well as a pattern
of drinking score, which is an estimation of alcohol-related
health risks. When comparing alcohol consumption
patterns in China (5.6 liters of pure alcohol per person
per year; 28% of lifetime non-drinkers; 57% of consump-
tion from spirits; alcohol use disorders 6.90% in men)
and Korea (14.8 liters of pure alcohol per person per
year; 12.8% of lifetime non-drinkers [5.1% of men and
20.4% of women]; 12.0% of men and 38.9% of women
were non-drinkers the year before the survey between
2001 and 2005 [6]; 81% of consumption from spirits;
alcohol use disorders 13.10% in men), one could expect
a higher PAF in Korea than China. However, this was
not observed given the different cancer incidence and
mortality patterns, as well as the different RR for alco-
hol consumption and cancer utilized and the cancer
sites included in PAF estimates.
The lower PAF for alcohol consumption in Korea com-
pared to other countries, particularly Western countries,
may be partly due to the fact that a large proportion of
the Korean population are slow metabolizers of acethal-
dehyde, a genotoxic substance formed endogenously from
alcoholic beverages. Aldehyde dehydrogenases (ALDH) is
the main enzyme responsible for detoxifying aldehyde,
and maintaining low levels of acetaldehyde during ethanol
oxidation [51]. Inactive ALDH2 enzyme is caused by a
mutant of ALDH2, known as the ALDH2*2 variant
allele. Both individuals homozygous and heterozygous
for ALDH2*2 are ALDH2-deficient, but homozygous
individuals have higher acetaldehyde levels after they
drink alcohol [52]. Accumulation of acetaldehyde after
drinking alcohol results in a flushing reaction, which is
common in Koreans, Japanese and Chinese, but not
Whites [53]. About 30% of East-Asian populations
have the ALDH2*2 variant allele, and therefore usually
avoid drinking alcohol, or drink lower quantities than
other population groups. Cancer risk, particularly esopha-
geal cancer risk, but possibly that of other cancers as well,
is increased in people who are slow metabolizers of acet-
haldehyde. It is possible that some self-selection takes
place, where individuals with a flush reaction (who are
thus more susceptible to cancer) drink less alcohol [9].
Another possible explanation for the lower PAF for alco-
hol consumption in Korea compared to Western countries
may be that the number of cancers attributable to other
factors such as smoking and infection is high. Hence the
relative proportion of cancers attributable to alcohol con-
sumption may appear smaller than that in other countries
when PAF is computed by dividing the alcohol-related
cancers by the total number of cancers, though the at-
tributable fraction may not be as low compared to other
countries. Furthermore, it is possible that the PAF for
alcohol consumption in Korea has been underestimated
due to the use of self-reported alcohol consumption.
A few studies have been published on alcohol con-
sumption and breast cancer risk among Asian women,
but their results are inconsistent [9]. Based on studies
mainly among Whites, it has been estimated that the
RR of female breast cancer increases with increasing
alcohol consumption by about 7% per 10 g/day; the es-
timates were somewhat lower (5%) in the pooling of
prospective cohort studies compared to estimates from
population-based (7.3%) or hospital-based (7.4%) case–
control studies [54]. In a new large study from the
United Kingdom including mainly Whites, the risk es-
timates per 10 g/day of pure alcohol were 12% (95% CI
9-14%) [55].
Alcohol consumption could increase breast cancer risk
by altering endogenous hormone levels. Studies among
Whites indicate that consumption of over 20 g/day of
pure alcohol substantially increases levels of estradiol,
free estradiol, estrone, androstenedione, testosterone and
free testosterone, while decreasing levels of SHBG [56].
The association between alcohol consumption and en-
dogenous hormones in Asian populations has not been
described in as much detail as in Whites; it is biologic-
ally plausible that the effect would be different given
similar doses of alcohol because of genetic variations and
other factors that may influence metabolism (proportion
of water to lean body mass, for example) [9].
Our study has both methodological strengths and
weaknesses. We based our PAF estimates for alcohol con-
sumption on the proportion of alcohol drinkers 20 years
of age or older in 1989, and the average alcohol consump-
tion among drinkers (g/day) in 1998 obtained from well
designed and well conducted population-based surveys
in Korea [10]. We chose to combine information from
these two time periods, as information on average alco-
hol consumption was not available in the 1989 survey.
We assumed that the combination of data on alcohol
consumption from 1989 and 1998 was representative of
the period of carcinogenesis related to alcohol con-
sumption, i.e., an approximately 20-year latency period
between mean exposure to alcohol and cancer inci-
dence and mortality in 2009. However, we cannot rule
out the possibility of under-reporting of alcohol con-
sumption, in particular among heavy drinkers, which is
common in the assessment of alcohol consumption in
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questionnaire-based surveys. While there is possibility
of underestimating the PAF for alcohol consumption
assessed by self-reporting, we believe the underestima-
tion through self-administered questionnaire would not
be large, because the Korean society has high tolerance
level for heavy alcohol drinking and drinkers are rela-
tively well accepted by Korean social norm [57].
There were a few published epidemiologic studies on
alcohol consumption and cancer in Korea which con-
tained risk estimates we could in our study: Studies
from one large-scale multi-cancer-site population-based
cohort study [17,18,22], two medium-sized cohort studies
[25,29], and several hospital-based case–control studies:
one on liver cancer with 203 cases [28]; two studies on
breast cancer, one with 108 cases [14], and another with
4,508 cases and which had updated data analysis per-
formed by the author [33]; and one study on colorectal
cancer with 596 cases [19]. Among them, the one cohort
study is a population-based prospective cohort study with
over 1 million subjects that can be considered representa-
tive of the entire adult Korean population [17,18]. Further-
more, the calculation of RRs of alcohol consumption in
the aforementioned study [17,18] was based on a statistical
model that adjusted for age and tobacco smoking. There-
fore the confounding effect that smoking might have on
alcohol consumption was resolved in our RR estimation.
Misclassification of alcohol consumption in both
the cohort and case–control studies could be due to
under-reporting among heavy drinkers, as well as under-
reporting in population groups that are not socially
expected to drink in Korea, such as women. Such mis-
classification could have biased these studies’ results
towards lower risk estimates. Conversely, the case–
control studies could be prone to recall bias, which
could have led to an over-estimation of risks. Although
the case–control study on breast cancer [14] reported
a statistically significant odds ratio of 1.15 for alcohol
drinkers compared to lifetime non-drinkers, which is
compatible with the international literature [9], more
studies would be needed to generate reliable risk
estimates.
Conclusions
In contrast with several countries in Western Europe,
where both alcohol consumption and alcohol-related
mortality is decreasing, Korea has the highest per capita
alcohol consumption among Asian countries according
to a recent report by the World Health Organization [6],
and the proportion of lifetime non-drinkers has decreased
over the last decade (12.0% in men and 38.9% in women
in 1995 vs. 5.1% in men and 20.4% in women between
2001 and 2005) [58]. Excessive alcohol consumption and
resulting adverse effects may be attributed to Korean cul-
ture, where alcohol drinking is pervasive. Peer persuasion
and pressure is very common in Korea when it comes to
alcohol consumption, which is considered almost essential
in among Korean business people [59]. Furthermore, mi-
nors in Korea have relatively easy access to alcohol, hence
regulations and control over alcohol consumption need to
be strengthened.
Thus, public health initiatives to reduce alcohol con-
sumption, in particular among Korean men, would have
a significant impact on cancer incidence and mortality
in the Republic of Korea. Among women, awareness of
the increased risk of breast cancer due to alcohol con-
sumption may impact drinking behavior.
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